Impulsivity, Neural Deficits and Cocaine Addiction
- Conditions
- Cocaine Dependence
- Registration Number
- NCT00744601
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Brief Summary
The purpose of this study is to assess neurocognitive and associated neural regions/circuitry disruptions relevant to impulsive relapse in cocaine-addicted subjects, and the relationship of the cognitive and neural mechanisms of impulsivity/decision-making to relapse style.
- Detailed Description
This study is designed to explore putative differences in impulsive behaviors and decision making in cocaine-addicted and healthy control subjects using functional magnetic resonance imaging (fMRI), single photon emission tomography (SPECT), and neurocognitive tasks. We predict that cocaine-addicted subjects will demonstrate neurocognitive and neural alterations in measures of impulsivity and decision-making when compared to healthy controls. That is, cocaine-addicted subjects will show both decreased activation and decreased resting measures of regional cerebral blood flow (rCBF) of the brain structures associated with impulsivity and decision-making. Furthermore, neurocognitive and neural deficits associated with impulsivity and decision-making will be associated with each other and with measures indicative of an impulsive relapse and altered decision making.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 90
- Cocaine-dependence (patient population) or no cocaine-dependence (control population).
- Other medical or psychiatric disorders that may effect neural functioning.
- Medications that may effect neural functioning.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determine if the brain regions involved in inhibition and decision-making are altered in cocaine-addicted subjects compared to healthy controls. 2 weeks In cocaine-addicted subjects, determine if neural deficits during disinhibition or decision-making are related to relapse following treatment. 6 months
- Secondary Outcome Measures
Name Time Method Assess the predictive validity of self-report measures of impulsive relapse. 6 months
Trial Locations
- Locations (1)
UT Southwestern Medical Center at Dallas, Divison on Addictions
🇺🇸Dallas, Texas, United States